{
    "0P00002ATF.F": {
        "short_name": "Gestys Sant\u00e9 Biotech",
        "long_name": "Gestys Sant&#195;&#169; Biotech",
        "currency": "EUR",
        "summary": "Ce FIA est un fonds d\u00e2\u0080\u0099investissement \u00c3\u00a0 vocation g\u00c3\u00a9n\u00c3\u00a9rale qui a pour objectif de gestion de permettre aux porteurs de parts d &#39;\u00c3\u00aatre associ\u00c3\u00a9s aux \u00c3\u00a9volutions des soci\u00c3\u00a9t\u00c3\u00a9s europ\u00c3\u00a9ennes du secteur de la sant\u00c3\u00a9 et plus particuli\u00c3\u00a8rement des biotechnologies, sur la dur\u00c3\u00a9e de placement recommand\u00c3\u00a9e.",
        "manager_name": "Jean-Laurent  Bruel",
        "manager_bio": "",
        "category": "Sector Equity Biotechnology",
        "family": "Gestys",
        "exchange": "FRA",
        "market": "dr_market"
    },
    "SELJLB.MI": {
        "short_name": "SELECTRA J. LAMARCK BIOTECH CLA",
        "long_name": "Selectra J. Lamarck Biotech Fund Class D",
        "currency": "EUR",
        "summary": "The main objective of this sub-fund is to profit from increasing share prices in the biotechnology sector. The focus is on mature top tier pharmaceutical biotech companies and companies with interesting pipeline of products in development in a single or numerous markets, like Nasdaq or NYSE. The followed investment policy will enable the Sub-Fund to increase overall return relative to the Nasdaq Biotech Index by active stock selection of companies, offering the most promising technology platform.",
        "manager_name": "Not  Disclosed",
        "manager_bio": "",
        "category": "Sector Equity Biotechnology",
        "family": "SELECTRA MANAGEMENT COMPANY S.A.",
        "exchange": "MIL",
        "market": "it_market"
    }
}